Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.
about
T cell receptor mimic antibodies for cancer therapyT cell receptor-like recognition of tumor in vivo by synthetic antibody fragmentTherapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor.An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivoAnti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptorTargeting the intracellular WT1 oncogene product with a therapeutic human antibody.TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells.T-cell-receptor-like antibodies - generation, function and applications.Function and Potentials of M. tuberculosis EpitopesOpportunities and challenges for TCR mimic antibodies in cancer therapyTCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibody.Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia.Therapeutic Antibodies against Intracellular Tumor AntigensIn silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census.TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
P2860
Q26768271-172A5242-F66E-4552-B0FC-5A6C4ADCDE78Q27322455-70E41397-337A-41D9-8E5C-154DE57728B8Q33992114-ECA1F118-3D60-460A-96ED-56077EEB4D86Q34042430-9713A74B-48FC-4BE7-85E3-ED694359D542Q34923734-FD04B087-1004-4D9E-97CA-B881AF43C0A6Q37072087-F11E547A-FEDE-4C3C-B0EA-F44A18EF4567Q37434176-09502943-11CE-4426-93A2-5C940A3605ABQ37659113-D5B39964-8332-4ED1-853D-221AF7DEA98FQ37952806-96FAB22F-C2A8-461A-8E22-ED2DB4E22C96Q37987723-D9B8852F-B03F-41FC-8E01-FEB59038CB5CQ38203257-86D72132-E234-4081-9C5C-76897D6F63F1Q38812269-59BB3199-9BC9-45FA-AF43-E5E29FD5E019Q38920996-495F8EE6-6A87-45DE-A417-3ED96F5F4B08Q39085019-9251283F-4AD9-4FA7-89B7-C89051E56210Q39718346-F966FBB2-D4A5-498B-A0B2-2E5257C2B121Q41462883-5B7E9133-27A4-4252-B0BE-7951806EB192Q41771171-652BBF5B-5F2E-4DB3-B9CA-C771FE3BF213Q52691571-908FEC33-3B44-4A5F-BE0F-491AA0F72AAE
P2860
Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Antitumor activity of immunoto ...... nst human melanoma xenografts.
@ast
Antitumor activity of immunoto ...... nst human melanoma xenografts.
@en
type
label
Antitumor activity of immunoto ...... nst human melanoma xenografts.
@ast
Antitumor activity of immunoto ...... nst human melanoma xenografts.
@en
prefLabel
Antitumor activity of immunoto ...... nst human melanoma xenografts.
@ast
Antitumor activity of immunoto ...... nst human melanoma xenografts.
@en
P2093
P2860
P1433
P1476
Antitumor activity of immunoto ...... nst human melanoma xenografts.
@en
P2093
Cyril Cohen
Galit Denkberg
Karolina Palucka
Michael Gallegos
Yoram Reiter
P2860
P304
P356
10.1158/0008-5472.CAN-08-0928
P407
P577
2008-08-01T00:00:00Z